Synopsis: Outcomes in SLE, whether measured as morbidity, mortality or
patient reported burdens of disease, are a result of a complex interplay
between genetic, biologic, socioeconomic and health system variables. Of these,
biologic variables, such as cytokines and molecular treatment targets, as well
as health system variables, such as health care quality, are potentially
amenable to change. In my PhD I will explore a new way to define treatment
response for clinical trials and assess the impact of quality of care on
patient outcomes, as two potentially modifiable factors in SLE.
Main supervisors: Dr Alberta Hoi
Associate supervisors: Prof Eric Morand, Dr Mandana Nikpour,
A.Prof Russell Buchanan
Panel chair: Prof Michael Hickey
Independent supervisors: Prof Geoffrey Littlejohn and Dr
Sarah Jones
ALL WELCOME
No comments:
Post a Comment